Bicara Therapeutics Inc. ... (BCAX)
NASDAQ: BCAX
· Real-Time Price · USD
9.74
-0.26 (-2.60%)
At close: Jun 17, 2025, 3:01 PM
Bicara Therapeutics Common Stock Revenue
Bicara Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Bicara Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
55
Market Cap
530.99M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|